What question did this study set out to answer?

This research aims to identify and characterize molecular subtypes of urothelial carcinoma (UC) to enhance precision therapy.

March 12, 2026

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Key Points

This research aims to identify and characterize molecular subtypes of urothelial carcinoma (UC) to enhance precision therapy.
Developed three UC clusters applicable for muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC)
Validated clusters using transcriptomic and proteomic datasets
Assigned publicly available UC cell lines to the clusters to create in vitro models
Clusters exhibit distinct molecular and biological signatures
Each cluster has unique prognostic and therapeutic characteristics

Abstract

We developed three UC clusters, applicable for MIBC and NMIBC, which were validated using transcriptomic- and proteomic datasets. Publically available UC cell lines were assigned to the clusters, to have in vitro models representing each cluster. The clusters differ in molecular and biological signatures, with distinct prognostic and therapeutic characteristics.

KI fragen

Bookmark